Side Navigation

X

CLSI M54-A

Principles and Procedures for Detection of Fungi in Clinical Specimens – Direct Examination and Culture; Approved Guideline, M54A
standard by Clinical and Laboratory Standards Institute, 10/01/2012

CLSI AUTO08-A

Protocols to Validate Laboratory Information Systems; Proposed Guideline, AUTO08AE
standard by Clinical and Laboratory Standards Institute, 01/01/2007

CLSI H47-A2

One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline – Second Edition., H47-A2
standard by Clinical and Laboratory Standards Institute, 01/01/2008

CLSI EP37

Supplemental Tables for Interference Testing in Clinical Chemistry, 1st Edition, EP37Ed1E
standard by Clinical and Laboratory Standards Institute, 04/01/2018

CLSI NBS05-A

Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AE
standard by Clinical and Laboratory Standards Institute,

CLSI EP10-A3-AMD

Preliminary Evaluation of Quantitative Clinical Laboratory Methods, Approved Guideline – Third Edition, EP10A3AMDE
standard by Clinical and Laboratory Standards Institute, 05/01/2014

CLSI POCT06

Effects of Different Sample Types on Glucose Measurements, 1st Edition, POCT06Ed1E
standard by Clinical and Laboratory Standards Institute, 05/01/2015

CLSI M38

Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Third Edition, M38Ed3E
standard by Clinical and Laboratory Standards Institute, 11/01/2017

CLSI QMS06-A3 (R2018)

Quality Management System: Continual Improvement; Approved Guideline – Third Edition, QMS06A3E
standard by Clinical and Laboratory Standards Institute, 06/01/2011

CLSI C59-A

Apolipoprotein Immunoassays: Development and Recommended Performance Characteristics; Approved Guideline, C59AE
standard by Clinical and Laboratory Standards Institute, 09/19/1997